Eagle Pharmaceuticals, Inc. financial data

Symbol
EGRX on OTC
Location
50 Tice Boulevard, Suite 315, Woodcliff Lake, NJ
Fiscal year end
December 31
Latest financial report
10-Q/A - Q2 2023 - Aug 9, 2023

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 181 % -22.7%
Quick Ratio 47.5 % +39.2%
Debt-to-equity 67.8 % +39.6%
Return On Equity 4.98 % -55.5%
Return On Assets 2.97 % -60.6%
Operating Margin 15.9 % -25%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 13M shares -2.24%
Common Stock, Value, Issued 18K USD 0%
Weighted Average Number of Shares Outstanding, Basic 13.1M shares +1.99%
Weighted Average Number of Shares Outstanding, Diluted 13.2M shares +2.48%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 258M USD -5.38%
Research and Development Expense 35.6M USD -20.1%
Costs and Expenses 217M USD +0.99%
Operating Income (Loss) 41M USD -29%
Nonoperating Income (Expense) -11.8M USD +32%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 29.2M USD -27.7%
Income Tax Expense (Benefit) 17.2M USD -1.96%
Net Income (Loss) Attributable to Parent 11.9M USD -47.6%
Earnings Per Share, Basic 1 USD/shares -52.7%
Earnings Per Share, Diluted 1 USD/shares -49.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 15.4M USD -58%
Accounts Receivable, after Allowance for Credit Loss, Current 115M USD +34%
Inventory, Net 42.5M USD -26.4%
Other Assets, Current 3.82M USD +31.6%
Assets, Current 187M USD -3.71%
Deferred Income Tax Assets, Net 30.7M USD +32.1%
Property, Plant and Equipment, Net 1.01M USD -30.6%
Intangible Assets, Net (Excluding Goodwill) 107M USD -4.51%
Goodwill 45M USD +4.59%
Other Assets, Noncurrent 33.4M USD +373%
Assets 405M USD +6.04%
Accounts Payable, Current 15.8M USD -20.7%
Accrued Liabilities, Current 73.2M USD +15.4%
Liabilities, Current 86.6M USD -20.5%
Operating Lease, Liability, Noncurrent 839K USD -62.8%
Other Liabilities, Noncurrent 4.26M USD +88.7%
Liabilities 153M USD +6.27%
Accumulated Other Comprehensive Income (Loss), Net of Tax -1.11M USD -149%
Retained Earnings (Accumulated Deficit) 122M USD +10.8%
Stockholders' Equity Attributable to Parent 252M USD +5.91%
Liabilities and Equity 405M USD +6.04%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -33.5M USD -102%
Net Cash Provided by (Used in) Financing Activities 12.6M USD
Net Cash Provided by (Used in) Investing Activities -12.6M USD -7375%
Common Stock, Shares Authorized 50M shares 0%
Common Stock, Shares, Issued 17.6M shares +0.56%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -33.4M USD -18.8%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 15.4M USD -58%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.32M USD +397%
Operating Lease, Liability 2.26M USD -39.4%
Depreciation 110K USD -37.9%
Payments to Acquire Property, Plant, and Equipment 58K USD -65.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 8.56M USD -67.1%
Lessee, Operating Lease, Liability, to be Paid 2.37M USD -41.1%
Property, Plant and Equipment, Gross 7.83M USD +0.95%
Operating Lease, Liability, Current 1.42M USD -3.66%
Lessee, Operating Lease, Liability, to be Paid, Year Two 413K USD -63.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.12M USD -32.9%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Lessee, Operating Lease, Liability, to be Paid, Year Three 0 USD -100%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1.5M shares 0%
Unrecognized Tax Benefits 0 USD
Operating Lease, Payments 421K USD +12.3%
Additional Paid in Capital 374M USD +4.31%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 20M USD +423%
Depreciation, Depletion and Amortization 446K USD -41.6%
Share-based Payment Arrangement, Expense 16.5M USD -6.12%
Interest Expense 6.09M USD +256%